EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Cancer · Sarcoma · Leukaemia · Breast Cancer (Locally Advanced or Metastatic) · Lung Cancer (Diagnosis) · Colorectal Cancer · Melanoma (Skin Cancer) · Bladder Cancer · Kidney Cancer · Pancreatic Cancer Metastatic · Liver Cancer (Primary and Metastatic) · Ovarian Cancer · Esophageal Cancer · Glioblastoma · Non-Melanoma Skin Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

District One Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (SAMI XI, dr) · SFM@districtonehospital.com · +14012275001

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Cancer · Period Problem

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Acute Kidney Injury · Chronic Kidney Diseases · Solid-organ Transplantation

Abroad (travel likely)Recruiting

Toulouse, France

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Sleep · Fatigue · Anxiety

Abroad (travel likely)RecruitingPHASE2, PHASE3

Houston, United States

Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer

Esophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China